Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: A review

Journal of Extra-Corporeal Technology

Volumn 40, Issue 1, 2008, Pages 27-42

  Boodram, Shalini ^a,b   Evans, Ed ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Inflammation; Inflammatory response; Leukocyte depletion; Leukocyte filter; Leukocyte filtration; Leukocytes

Indexed keywords

BRAIN FUNCTION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; ENDOTHELIUM CELL; FILTER; HEART SURGERY; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LEUKOCYTE ACTIVATION; LEUKOCYTE DEPLETING FILTER; LUNG FUNCTION; MULTIPLE ORGAN FAILURE; REVIEW;

EID: 41949129617     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg. 1997;85:766-82.
2. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion. 1999;14:269-77.
3. Menasche P, Edmunds H Jr. Extracorporeal circulation: the inflammatory response. In: Cohn LH, Edmunds H Jr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hill; 2003; 349-360.
4. Wan S, LeClerc J, Vincent J. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676-92.
5. Marieb EN. Human Anatomy and Physiology, 5th ed. New Jersey: Benjamin Cummings; 2001.
6. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1998;66:S12-6.
7. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002;82:521-34.
8. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
9. Li S, Price R, Phiroz D, Swan K, Crane TA. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol. 2005;37:180-8.
10. Terumo Cardiovascular Systems, Corp. LeukoGuard-6™ LG Pall leukocyte reduction arterial blood filter for extracorporeal service. 2002. Available online at http://www.terumo-cvs.com/doc/ EC47C_LeukoGuardLGBrochure_December2002.pdf. Accessed September 12, 2006.
11. Terumo Cardiovascular Systems, Corp. LeukoGuard BC Pall leukocyte reduction blood cardioplegia filter. 2002. Available online at http://www.terumo-cvs.com/doc/EC56D_LeukoGuardBCBrochure_December2002.pdf. Accessed September 12, 2006.
12. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leukocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205-10.
13. de Vries AJ, Gu YJ, van Oeveren W. The clinical effects and mechanisms of leukocyte depletion filters during cardiac surgery. Ann Card Anesth. 2005;8:117-24.
14. Thurlow PJ, Doolan L, Sharp R, Sullivan M, Smith B. Studies of the effect of Pall leukocyte filers LG6 and AV6 in an in vitro simulated extracorporeal circulatory system. Perfusion. 1995;10:291-300.
15. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Filtration of activated granulocytes during cardiopulmonary bypass surgery: a morphological and immunological study to characterize the trapped leukocytes. J Lab Clin Med. 2000;135:238-46.
16. Aybek T, Kahn MF, Dogan S, et al. Cardiopulmonary bypass impairs left ventricular function determined by conductance catheter measurement. Thorac Cardiovasc Surg. 2003;51:301-5.
17. Gorcsan J 3rd, Gasior TA, Mandarino WA, Deneault DG, Hattler BG, Pinsky MR. Assessment of the immediate effects of cardiopulmonary bypass of left ventricular perfuomance by on-line pressure area relations. Circulation. 1994;89:180-90.
18. Khuri SF, Axford TC, Garcia JP, et al. Metabolic correlates of myocardial stunning and the effect of cardiopulmonary bypass. J Card Surg. 1993;8(Suppl 2):262-70.
19. Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg. 2001;71:1491-5.
20. Matheis G, Scholz M, Gerber J, Abdel-Rahman U, Wimmer-Greinecker G, Moritz A. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43-9.
21. Di Salvo C, Louca LL, Pattichis K, Hooper J, Walesby RK. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report. J Cardiovasc Surg (Torino). 1996;37(Suppl 1):93-100.
22. Whitaker DC, Stygall J, Harrison MJ, et al. Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. Perfusion. 2006;21:55-60.
23. Leal-Noval SR, Amaya R, Herruzo A, et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg. 2005;80:1394-400.
24. Sahlman A, Ahonen J, Salo JA, Ramo OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand. 2001;45:558-63.
25. Heggie AJ, Corder JS, Crichton PR, et al. Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1). Perfusion. 1998;13:17-25.
26. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klovekorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 2000;120:642-50.
27. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leucocyte- depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205-10.
28. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956-061.
29. Murai N, Imazeki T, Shioguchi S, et al. Leukocyte-depleted continuous blood cardioplegia for coronary artery bypass grafting. Jpn Heart J. 2000;41:425-33.
30. Sawa Y, Taniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation. 1996;93:1640-6.
31. Hayashi Y, Sawa Y, Fukuyama N, et al. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic cross-clamping for more than 120 minutes. J Thorac Cardiovasc Surg. 2003;126:1813-21.
32. Browning PG, Pullan M, Jackson M, Rashid A. Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion. 1999;14:371-7.
33. Alexiou C, Tang AT, Sheppard SV, et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomized study. Eur J Cardiothorac Surg. 2004;26:294-300.
34. Chen Y, Tsai W, Lin C, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:634-43.
35. Alexiou C, Tang AT, Sheppard SV, et al. A prospective randomized study to evaluate the effect of leukodepletion on the rate of alveolar production of exhaled nitric oxide during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:2139-45.
36. Sheppard SV, Gibbs RV, Smith DC. Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production? Perfusion. 2004;19:7-10.
37. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2004;78:1339-44.
38. Sheppard SV, Gibbs RV, Smith DC. Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indicies in patients with mild lung dysfunction? Br J Anaesth. 2004;93:789-92.
39. Sutton SW, Patel AN, Chase VA, et al. Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement. Perfusion. 2005;20:21-9.
40. Mihaljevic T, Tonz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study. J Thorac Cardiovasc Surg. 1995;109:1138-45.
41. Fabbri A, Manfredi J, Piccin C, et al. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16(Suppl):11-8.
42. Tang ATM, Alexiou C, Hsu J, et al. Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg. 2002;74:372-7.
43. Whitaker DC, Newman SP, Stygall J, Hope-Wynne C, Harrison MJ, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2004;25:267-74.
44. Chen Y, Tsai W, Lin C, et al. Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg. 2002;123:218-24.
45. Stefanou DC, Gourlay T, Asimakopoulos G, Taylor KM. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion. 2001;16:51-8.
46. Mair P, Hoermann C, Mair J, Margreiter J, Puschendorf B, Balogh D. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery. Acta Anaesthesiol Scand. 1999;43:452-7.
47. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S, Repo H. Activation of neutrophils and monocytes b a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;129:851-9.
48. Baksaas ST, Flom-Halvorsen HI, Ovrum E, Mollnes TE, Brosstad F, Svennevig JL. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14:107-17.
49. Salamonsen RF, Anderson J, Anderson M, Bailey M, Magrin G, Rosenfeldt F. Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg. 2005;79:2032-9.
50. Samankatiwat P, Samartzis I, Lertsithichai P, et al. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion. 2003;18:95-105.
51. Gu YJ, de Vries AJ, Vos P, Boonstra PW, van Oeveren W. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann Thorac Surg. 1999;67:604-9.
52. de Vries AJ, Gu YJ, Post WJ, et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion. 2003;18:31-8.
53. Olivencia-Yurvati AH, Wallace WE, Wallace N, et al. Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation. Perfusion. 2002;17:35-9.
54. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status postcardiopulmonary bypass. Perfusion. 2003;18:23-31.
55. Olivencia-Yurvati AH, Wallace N, Ford S, Mallet RT. Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection. Perfusion. 2004;19:S13-9.
56. Baksaas ST, Videm V, Mollnes TE, et al. Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion. 1998;13:429-36.
57. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747-54.
58. Hamada Y, Kawachi K, Nakata T, Kohtani T, Takano S, Tsunooka N. Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery. Artif Organs. 2001;25:1004-8.
59. Gunaydin S, McCusker K, Vijay V, et al. Clinical significance of strategic leukocyte filtration in different risk cohorts undergoing cardiac surgery. Filtration. 2005;1:95-106.
60. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51:363-8.